Clinical trial
Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With…
NCT00407277 · Centre for Addiction and Mental Health, Other · Completed
Key facts
| NCT number | NCT00407277 |
|---|---|
| Title | Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia |
| Official title | Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia |
| Lead sponsor | Centre for Addiction and Mental Health, Other |
| Collaborators | Canadian Psychiatric Research Foundation |
| Status | Completed |
| Study type | Interventional |
| Conditions | Smoking, Nicotine Dependence, Schizophrenia, Schizophreniform Disorders, Schizoaffective Disorder, Psychosis |
| Intervention type | Behavioral, Drug, Other |
| Interventions | Nicotine patch, placebo, smoking cessation group therapy |
| Enrollment | 120 |
| Start date | Feb 1, 2007 |
| Primary completion | Aug 1, 2008 |
| First posted | Dec 4, 2006 |
| Last update posted | Mar 18, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: